Medicare would cover hereditary cancer genetic testing, preventive surgeries, and more frequent screenings.
Right now, Medicare does not clearly cover certain services for people at high risk of hereditary cancer. This bill would change that, allowing Medicare to cover genetic testing for those at risk, specific surgeries to reduce cancer risk, and more frequent screenings for those with inherited mutations. This would help people with a family history of cancer or an inherited gene mutation get the care they need.
Today, Medicare does not explicitly cover germline mutation testing for those at risk, certain risk-reducing surgeries, or increased frequency of evidence-based screenings for people with hereditary cancer gene mutations. After this bill, Medicare would cover germline mutation testing for eligible individuals, specific risk-reducing surgeries, and more frequent evidence-based screenings (at least annually) for those with inherited cancer mutations.
HR 4752 · 119th Congress · July 23, 2025 · AI Summary by gemini-2.5-flash · 8/10
Sign in to see your representatives' phone numbers
5 filings mentioned this bill
Amounts reflect total quarterly lobbying spend reported to the Senate, not bill-specific spending. Source: Senate LDA filings.